Bacterin reported preliminary third quarter financial results, including a total revenue increase over the same period last year.
The company is focused on bone graft material and coatings for medical applications. The company expects to report total third quarter revenue at $8.4 million to $8.5 million. This would be a 6 percent to 7 percent increase when compared with the third quarter of 2013.
If all goes as planned, the company will have reported year-over-year revenue growth for four straight quarters.
"After meeting our goal of stabilizing the business by the end of 2013, we began investing in new products and strengthening our sales force," said Bacterin CEO Dan Goldberger. "We are now starting to realize the benefits of these investments and we expect to see our revenue accelerate by the end of 2015."
Mr. Goldberger recently appeared on the FOX Business Network's Open Bell with Maria Bartiromo to talk about regenerative medicine as it applies to bone, tendons and skin. He also promoted toe company's efforts with Circle of Life, an accredited tissue bank.